DLR assay system

The Dual-Luciferase® Reporter kit from Promega is a popular luminescent reporter assay to study gene transcription and regulation.

Dr Martin Mangold Dr Martin Mangold
Application Specialist, BMG LABTECH HQs
Dr Martin Mangold

Dr Martin Mangold

BMG LABTECH HQs

Application Scientist

linkedin-icon

About Dr Martin Mangold

Dr. Martin Mangold works as an Applications Specialist at BMG LABTECH headquarters in Ortenberg, Germany. He studied biology with a focus on biochemistry and cell biology at the University of Bonn before specializing in pharmaceutical sciences and drug interactions in his doctoral studies. During his time in the pharmaceutical department, Dr. Mangold gained expertise in protein sciences, binding and interaction studies, and enzyme kinetics as part of an interdisciplinary team of chemists, pharmacists and biologists. Since 2021, Dr. Mangold has been part of the BMG LABTECH team where he authors application notes, performs training courses and supports scientific customers.

Areas of Expertise

  • Protein science and interaction studies
  • Protein expression and purification
  • Cell biology and cell-based assays
  • Compound screening
  • Enzyme kinetics
  • Biochemistry

Academic Degrees

degree-icon
PhD in Pharmaceutical Sciences Friedrich-Wilhelm-Universität Bonn
degree-icon
MSc Degree in Drug Research Friedrich-Wilhelm-Universität Bonn
degree-icon
BSc Degree in Biology Friedrich-Wilhelm-Universität Bonn

The Dual-Luciferase® Reporter (DLR™) assay system from Promega Corp. provides a luminescent reporter assay to study gene transcription and regulation. The activities of two luciferases are measured sequentially from a single sample by a luminescence plate reader reporting the transcription of the gene of interest and a transfection control.

Fig. 1: Explanation of DLR assay system

Both assays can be completed in about 4 seconds using a luminometer with reagent auto-injectors, such as in the Omega seriesVANTAstar®CLARIOstar®, and PHERAstar® FSX microplate readers. In the DLR™ assay system, both reporters yield linear assays with attomole sensitivities and no endogenous activity in the experimental host cells. Furthermore, the integrated format of the DLR™ assay provides rapid quantitation of both reporters either in transfected cells or in cell-free transcription/translation reactions.

Fig. 2: Dual Luciferase Reaction - Luciferase Assay Reagent II (LAR II) is injected in the first step and the Firefly reaction is started. Stop and Glo® buffer is injected in the second step, which quenches the Firefly reaction and initiates the Renilla reaction.

Using additional luciferases, with different emission peaks allow to set up huge luminescence multiplexing approaches using six different readouts. With the help of the CLARIOstar or VANTAstar and their luminescence spectral scanning feature, ideal combinations of different luciferase to be used in the same run can be identified.

Frequently asked questions

  • What are Dual Luciferase® Reporter assays?

    Dual Luciferase® Reporter (DLR) assays are luminescent reporter assays to study gene transcription and regulation. The activities of two luciferases are measured sequentially from a single sample by a luminescence plate reader.
  • Why are microplate readers important for Dual Luciferase® Reporter assays?

    Microplate readers provide rapid, automated, and reproducible measurements, significantly increasing efficiency and data reliability of Dual Luciferase® Reporter assays.
  • Can microplate readers be integrated into automated laboratory systems for Dual Luciferase® Reporter assays?

    Yes, advanced microplate readers can be integrated with automation systems to facilitate high-throughput screening and streamline workflow processes in laboratories performing Dual Luciferase® Reporter assays.
  • What luciferase enzymes are typically used in Dual Luciferase® Reporter assays?

    A Dual Luciferase® Reporter assay measures two luciferases (usually firefly and Renilla) in the same well sequentially, allowing normalization of the experimental firefly signal to a control Renilla signal.
  • Why use a Dual Luciferase® Reporter instead of a single-luciferase assay?

    A Dual Luciferase® Reporter assay improves data accuracy by accounting for transfection efficiency, cell viability, and other well-to-well variations through internal normalization. 
  • How do I optimize timing between the two luciferase readings?

    Follow the kit’s recommended timing (often a brief delay after substrate addition) to maximize signal separation and reduce cross-talk; validate by a short pilot run.
  • How should I normalize data in Dual Luciferase® Reporter assays?

    Normalize Firefly luciferase (reporter) to Renilla luciferase (control) by calculating the ratio, which reduces plate-to-plate and transfection variability.
  • Can I run Dual Luciferase® Reporter assays with promoter and enhancer screens?

    Yes. Dual Luciferase® Reporter is well-suited for promoter activity studies, microRNA target validation, and screening where internal normalization is critical.
  • How should I control for plate-to-plate variation?

    Include internal controls (e.g., Renilla only, Firefly only, or a constant control) on every plate and use the Firefly/Renilla ratio for comparisons.
  • How do I troubleshoot weak signals or high background?

    Check reagent handling, substrate freshness, lysis efficiency, plate cleanliness, timing between injections, and instrument calibration. Run a positive control to verify assay performance.

Configure your microplate reader and get an initial recommendation!

Newsletter Sign-up